openPR Logo
Press release

In Vitro Fertilization Test Market is projected to expand at a CAGR of ~6% from 2021 to 2031

11-30-2021 10:54 AM CET | Health & Medicine

Press release from: Transparancy Market Research

In Vitro Fertilization Test Market

In Vitro Fertilization Test Market

In Vitro Fertilization Test Market: Introduction

According to the report, the global in vitro fertilization test market was valued over US$ 1.5 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. The surge in inclination toward delayed pregnancies, number of fertility clinics across the globe, and fertility tourism is anticipated to drive the global in vitro fertilization test market from 2021 to 2031. Europe is expected to account for a significant share of the global in vitro fertilization test market during the forecast period. The extent of usage varies widely across countries in Europe, which can be attributed to legislation, affordability, reimbursement, and norms surrounding childbearing and conception. The adoption of ART legislation in Europe has increased over the past few years, with all countries having some form of legislation. Countries with complete coverage of treatments via national health plans, such as the U.K., Spain, and Italy have the highest level of ART utilization.

The market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2031. Increase in patient awareness about fertility treatments, rise in infertility issues owing to changing lifestyle, high stress level, and delayed pregnancy are the key factors propelling the market in Asia Pacific.

Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82310

Decline in Fertility Rates to Propel Market

Over the past few decades, fertility patterns across the world have changed dramatically. The global fertility rate has touched unprecedented low levels. According to a report published by the United Nations (UN), the global fertility rate declined from 3.2 live births per woman in 1990 to 2.5 in 2019. Europe has the lowest fertility rate of 1.7 children per woman. The global fertility rate is expected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050.

According to Child Trend, a non-profit research organization, fertility rates in the U.S. declined sharply during the ‘baby boomer’ years of the 1950s, early 1960s, and 1976 (118 and 65 births per 1,000 women of childbearing age for 1960 and 1976, respectively). Since the 1970s, fertility rates have been relatively stable, varying between 64 and 71 births per 1,000 women. There were small peaks in 1990 and 2007, but rates have dropped since then. They are the lowest in the recent history, standing at 63 births per 1,000 women in 2013.

Request for Analysis of COVID19 Impact on In Vitro Fertilization Test Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82310

According to the Department of Family & Community Services Australia, fertility in Australia has been decreasing for a considerable time. The replacement fertility rate is around 2.1. The total fertility rate (TFR) was at its maximum level (3.6) observed in the 20th century in 1961. Throughout the 1970s and 1980s, TFR fluctuated around 1.8 or 1.9, with a small but steady decline throughout the 1990s. In 1999, Australia’s TFR was 1.75, dropping from 1.76 of the previous year. This was the minimum level observed in the 20th Century.

The fertility rate decreases as age increases. Massive urbanization in developing countries is a major factor responsible for the decline in fertility rates. Nearly 4 in 5 people (78%) are delaying pregnancy, focusing on other aspects of life. The continuous decline in fertility rates across the world drives the global in vitro fertilization test market.

Buy Market Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=82310<ype=S

Preimplantation Genetic Testing to Dominate Global Market

In terms of test type, the global in vitro fertilization test market has been classified into sperm aneuploidy test, genetic compatibility test, preimplantation genetic testing, endometrial receptivity analysis, noninvasive prenatal testing, and others. The preimplantation genetic testing (PGD) segment is expected to dominate the global in vitro fertilization test market from 2021 to 2031. The usage of PGD for chromosomal aberrations, aneuploidy screening, gender selection, single gene disorder, HLA typing, and X-linked diseases has been increasing rapidly due to benefits associated with better pregnancy rate and birth of a healthy child. Aneuploidy screening using PGD has eased the method of detecting the risk of a syndrome caused due to variation in the number of chromosomes. This is expected to drive the segment during the forecast period.

Read More Information:

https://www.transparencymarketresearch.com/in-vitro-fertilization-market.html

Fertility Clinics to be Major End Users

Based on end user, the global in vitro fertilization test market has been divided into fertility clinics, hospitals, and others. The fertility clinics segment is likely to account for a significant share of the global in vitro fertilization test market by 2031. Rise in fertility tourism and insurance coverage and government initiatives in registration of fertility clinics to provide safe and high quality IVF treatments are likely to fuel the growth of the fertility clinics segment.

Competition Landscape of In Vitro Fertilization Test Market

The report provides profiles of leading players operating in the global in vitro fertilization test market. These include CooperSurgical, Inc., Esco Micro Pte Ltd., FUJIFILM Irvine Scientific, Hamilton Thorne, Inc., Vitrolife AB, IVFtech ApS, Nidacon International AB, Igenomix, Thermo Fisher Scientific, Cook, Genea Biomedx, FertiPro N.V, Kitazato Corporation, PerkinElmer, Inc., Natera, Takara Bio, Inc., iGLS, and CiceroDx.

Browse more Market Reports:

Assistive Listening Devices Market:

https://www.transparencymarketresearch.com/assistive-listening-devices-market.html

Portable Oxygen Concentrators Market:

https://www.transparencymarketresearch.com/portable-oxygen-concentrators.html

Aromatherapy Market:

https://www.transparencymarketresearch.com/aromatherapy-market.html

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Fertilization Test Market is projected to expand at a CAGR of ~6% from 2021 to 2031 here

News-ID: 2479464 • Views: 136

More Releases from Transparancy Market Research

Nuclear Imaging Services Market Growth to Remain Stable during the Projection Pe …
Nuclear Imaging Services Market Nuclear medicine (NM) is a field of medical imaging that employs the usage of tiny quantities of radioactive chemicals for diagnosis as well as treatment of many illnesses. Nuclear imaging entails the application of methods that give quantitative as well as qualitative data on physiological processes inside the body of beings. Nuclear medicine procedures such as PET, scintiography, and single photon emission computed tomography (SPECT) make use
Hemophilia Market Size to Grow Exponentially during the Assessment Period
Hemophilia, a group of common hemorrhagic inherited disorders, that interferes with normal blood coagulation. The group of inherited ailments leads to excessive bleeding or prolonged bleeding, and may infest even after minor injuries. Its two most common types Hemophilia A and B fall into severe hereditary hemorrhagic disorders, where the former affects more than 4 lakhs males worldwide has a higher prevalence. The hemophilia market has made strides pivoting on
Near Infrared Imaging Market Estimated to Rise Profitably during the Foreseeable …
Global Near Infrared Imaging Market: Overview Near infrared imaging electromagnetic spectrum based imaging offers better clarity as compared to conventional imaging. It is The global near infrared imaging market is expected to witness an astounding growth during the forecast period 2018 to 2026. The rising trend of research activities to develop better and advanced diagnostics is projected to help the global near infrared market expand in the forthcoming years. An upcoming Transparency
Cough Suppressant Drugs Market Will Generate New Growth Opportunities in Upcomin …
Cough Suppressant Drugs Market - Snapshot Three types of medicines can ease a cough caused by a cold or bronchitis: cough suppressants, expectorants, and ointments you apply to your skin called topicals. Suppressants do their job by blocking your cough reflex. Dextromethorphan is the most common ingredient for this. You’ll see it listed as on the bottle or package. This type of medication isn’t used to treat a cough with mucus.

All 5 Releases


More Releases for Vitro

In Vitro Fertilization Banking Services Market Report
According to the research conducted by GME Global In Vitro Fertilization Banking Services Market will expand at a CAGR value of 9.35% between 2021-2026. The major factors expected to be the drivers of market growth include the increasing cases of infertility worldwide, the rising cancer cases which have resulted in the incidence of infertility among women and men, a worldwide increase in disposable income, and the rise in fertility tourism
Asia Pacific In Vitro Diagnostics Market Size
Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is categorized into several diagnostic techniques, among which, the immunodiagnostic and clinical chemistry
Europe In-vitro Diagnostics Market
As per the latest report by Graphical Research titled “Europe In-vitro Diagnostics Market analysis based on Product Type, Service Type, Technology, Application, End-User, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024”, Estimated to reach USD 21 billion by 2024. Major industry competitors operating in Europe in-vitro diagnostics market are Abbott, Becton Dickinson, BioRad, BioMerieux, Cephied, Danaher, Grifols, Johnson & Johnson, Luminex, Roche Diagnostics, Siemens,
In Vitro Toxicity Testing Global Market 2019
Press Release – 23 Jan 2019 Research and Development News -- . . Latest Update "In Vitro Toxicity Testing: Technologies and Global Markets" with Industries Survey | Global Current Growth and Future. ' ' The global in vitro toxicity market should grow at a compound annual growth rate (CAGR) of xxx during the forecast period (20182023). Every year more chemicals are synthesized and are brought into the market. The cost of animal testing is
In Vitro Diagnostics 2018 : Global In-Vitro Diagnostics (IVD) Market: Industry A …
Press Release - 10 April 2018 Global Research and Development News -- . . Report Description- '
Indian In Vitro Diagnostics Market Analysis 2018
The Indian IVD market is valued at more than US$ 500 Million, and is expected to surpass US$ 1.5 Billion by 2018 growing steady at a CAGR of 20%. This remarkable growth can be attributed to increased healthcare awareness, desire to undergo preventive health checkups, availability of disease specific tests, corporate setups promoting health focus of employees, and drift from manual to semi-automated and automated equipment. Emergence of new concepts